Citation Tools

Original research
Exploration of modified progression-free survival as a novel surrogate endpoint for overall survival in immuno-oncology trials

Download to a citation manager

Cite this article as:
Wang Z, Wu H, Xie L, et al
Exploration of modified progression-free survival as a novel surrogate endpoint for overall survival in immuno-oncology trials